Enhancement of vascularization and granulation tissue formation by growth factors in human platelet-rich plasma-containing fragmin/protamine microparticles

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 97 B, Issue 2, 2011, Pages 373-380

  Takikawa, Megumi ^a   Nakamura, Shin Ichiro ^a   Nakamura, Shingo ^a   Nambu, Masaki ^a   Ishihara, Masayuki ^a   Fujita, Masanori ^a   Kishimoto, Satoko ^b   Doumoto, Takashi ^a   Yanagibayashi, Satoshi ^a   Azuma, Ryuichi ^a   Yamamoto, Naoto ^a   Kiyosawa, Tomoharu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

heparin binding growth factors; microparticles; platelet rich plasma (PRP); tissue formation; vascularization

Indexed keywords

GROWTH FACTOR; MICROPARTICLES; PLATELET-RICH PLASMA (PRP); TISSUE FORMATION; VASCULARIZATION;

CELL CULTURE; ENDOTHELIAL CELLS; GRANULATION; PEPTIDES; PLASMAS; PLATELETS; POLYSACCHARIDES;

TISSUE;

CARRIER PROTEIN; DALTEPARIN; FRESH FROZEN PLASMA; GROWTH FACTOR; PROTAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ELASTIC TISSUE; FIBROBLAST; GRANULATION TISSUE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO CULTURE; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PLATELET MICROPARTICLE; SKIN FIBROBLAST; THROMBOCYTE RICH PLASMA; VASCULARIZATION;

ANIMALS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; DALTEPARIN; ENDOTHELIAL CELLS; FIBROBLASTS; GRANULATION TISSUE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-RICH PLASMA; PROTAMINES;

EID: 79953800313     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31824     Document Type: Article

References (23)

1. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P,. The use of autologous platelet gel to treat difficult-to-heal wounds: A pilot study. Transfusion 2004; 44: 1013-1018. (Pubitemid 38823807)
2. Pietramaggiori G, Kaipainen A, Czeczuga JM, Wagner CT, Orgill DP,. Freeze-dried platelet-rich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regeneration 2006; 14: 573-580. (Pubitemid 44470074)
3. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR,. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638-646. (Pubitemid 128641964)
4. Sugimori E, Shintani S, Ishikawa K, Hamakawa H,. Effects of apatite foam combined with platelet-rich plasma on regeneration of bone defects. Dent Mater J 2006; 25: 591-596. (Pubitemid 44891337)
5. Marx RE,. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent 2001; 10: 225-228.
6. Man D, Plosker H, Winland-Brown JE,. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001; 107: 229-237; discussion 238-239.
7. Bhanot S, Alex JC,. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 2002; 18: 27-33. (Pubitemid 34133954)
8. Powell DM, Chang E, Farrior EH,. Recovery from deep-plane rhytidectomy following unilateral wound treatment with autologous platelet gel: A pilot study. Arch Facial Plast Surg 2001; 3: 245-250.
9. Abuzeni PZ, Alexander RW,. Enhancement of autologous fat transplantation with platelet rich plasma. Am J Cosmet Surg 2001; 18: 59-70.
10. Kevin S. Sadat, Anthony C. Corrado,. Platelet-rich plasma (PRP) utilized to promote greater graft volume retention in autologous fat grafting. Am J Cosmet Surg 2006; 23: 203-211.
11. Nakamura S-I, Ishihara M, Takikawa M, Murakami K, Kishimoto S, Nakamura S, Yanagibayashi S, Kubo S, Yamamoto N, Kiyosawa T,. Platelet-rich plasma (PRP) promotes survival of fat-grafts in rats. Ann Plast Surg 2010; 65: 101-106.
12. Nakamura S, Kanatani Y, Kishimoto S, Nakamura S-I, Ohno C, Horio T, Masanori F, Hattori H, Tanaka Y, Kiyosawa T, Maehara T, Ishihara M,. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization. J Biomed Mater Res A 2009; 91: 814-823.
13. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE,. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119 (1 Suppl): 64S-94S. (Pubitemid 32154195)
14. Wolzt M, Weltermann A, Nieszpaur-Los M, Schneider B, Fassolt A, Lechner K, Eichler HG, Kyrle PA,. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man. Thromb Haemostasis 1995; 73: 439-443.
15. Pan M, Suarez de Lezo J, Medina A, Romero M, Hernandez E, Segura J, Melian F, Wanguemert F, Landin M, Benitez F, Amat M, Velasco F, Torres A,. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol 1997; 80: 1336-1338. (Pubitemid 27513336)
16. Nakamura S, Nambu M, Ishizuka T, Hattori H, Kanatani Y, Takase B, Kishimoto S, Amano Y, Aoki H, Kiyosawa T, Ishihara M, Maehara T,. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization. J Biomed Mater Res A 2008; 85: 619-627. (Pubitemid 351632873)
17. Salmivirta M, Lidholt K, Lindahl U,. Heparan sulfate: A piece of information. FASEB J 1996; 10: 1270-1279. (Pubitemid 26307512)
18. Lindahl U, Lidholt K, Spillmann D, Kjellen L,. More to "heparin" than anticoagulation. Thromb Res 1994; 75: 1-32.
19. Ishihara M, Ono K,. Structure and function of heparin and heparan sulfate: Heparinoid library and modification of FGF-activities. Trends Glycosci Glycotechnol 1998; 10: 223-233.
20. Kishimoto S, Nakamura S, Nakamura S-I, Kanatani Y, Hattori H, Tanaka Y, Harada Y, Tagawa M, Mori Y, Maehara T, Ishihara M,. Fragmin/protamine microparticle-coated matrix immobilized cytokines to stimulate various cell proliferations with low serum media. Artif Organs 2009; 33: 431-438.
21. Chen FM, Zhang M, Wu ZF,. Toward delivery of muptiple growth factors in tissue engineering. Biomaterials 2010; 31: 6279-6308.
22. Scimeca CL, Bharara M, Fisher TK, Kimbriel H, Armstrong DG,. Novel use of platelet-rich plasma to augment curative diavetic foot surgery. J Diabetes Sci Technol 2010; 4: 1121-1126.
23. Kishimoto S, Hattori H, Nakamura S, Amano Y, Kanatani Y, Tanaka Y, Mori Y, Harada Y, Tagawa M, Ishihara M,. Expansion and characterization of human bone marrow-derived mesenchymal stem cells cultured on fragmin/protamine microparticle-coated matrix with fibroblast growth factor-2 in low serum medium. Tissue Eng Part C Methods 2009; 15: 523-527.